Lyons Ready Care Plant-Based Protein Shake Vanilla recall — FDA F-1647-2022
Findings and potential for Cronobacter sakazakii and Clostridium botulinum.
Complete FDA and NHTSA recall records dated in September 2022.
These records include useful source details for the selected month.
Findings and potential for Cronobacter sakazakii and Clostridium botulinum.
Findings and potential for Cronobacter sakazakii and Clostridium botulinum.
Findings and potential for Cronobacter sakazakii and Clostridium botulinum.
Findings and potential for Cronobacter sakazakii and Clostridium botulinum.
Findings and potential for Cronobacter sakazakii and Clostridium botulinum.
Findings and potential for Cronobacter sakazakii and Clostridium botulinum.
Findings and potential for Cronobacter sakazakii and Clostridium botulinum.
Findings and potential for Cronobacter sakazakii and Clostridium botulinum.
Findings and potential for Cronobacter sakazakii and Clostridium botulinum.
Findings and potential for Cronobacter sakazakii and Clostridium botulinum.
Findings and potential for Cronobacter sakazakii and Clostridium botulinum.
Firm received complaints of leaking cups, black liquid, and black particulates in the 24% Sucrose Solution.
Findings and potential for Cronobacter sakazakii and Clostridium botulinum.
Firm received complaints of leaking, black liquid, and black particulates in the product vials.
Findings and potential for Cronobacter sakazakii and Clostridium botulinum.
Findings and potential for Cronobacter sakazakii and Clostridium botulinum.
Findings and potential for Cronobacter sakazakii and Clostridium botulinum.
Labeling: Product Contains Undeclared API - product contains undeclared ethyl alcohol
cGMP deviation: Product held outside of appropriate temperature storage conditions.
cGMP deviation: Product held outside of appropriate temperature storage conditions.
cGMP deviation: Product held outside of appropriate temperature storage conditions.
CGMP Deviations: Product complaints reporting the product to have a gritty texture and lack of effectiveness.
cGMP deviation: Product held outside of appropriate temperature storage conditions.
CGMP Deviations: A foreign matter identified as teflon was found in the Active Pharmaceutical Ingredient (API) used in the manufacture of Neomycin Sulfate Tablets, USP 500 mg.
Use this page to compare the recalls reported during the month, then open an individual record for the exact reason, classification, company, remedy or distribution information available from the official source. Monthly counts are descriptive, not a safety rating.